Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings

scientific article published on 22 February 2016

Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S11904-016-0308-X
P698PubMed publication ID26898645
P5875ResearchGate publication ID295687807

P2093author name stringAlbert Y Liu
C Bradley Hare
Julia L Marcus
Stephanie E Cohen
Jonathan E Volk
Oliver Bacon
Jess Pinder
P2860cites workSTD/HIV risk among adults in the primary care setting: are we adequately addressing our patients' needs?Q39943298
The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugsQ41222547
Drug resistance and plasma viral RNA level after ineffective use of oral pre-exposure prophylaxis in womenQ41601407
Incident Hepatitis C Virus Infections Among Users of HIV Preexposure Prophylaxis in a Clinical Practice SettingQ42847376
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort studyQ46333832
Detection of acute HIV infections in high-risk patients in California.Q46438877
STD/HIV Prevention Practices Among Primary Care Clinicians: Risk Assessment, Prevention Counseling, and TestingQ57758880
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenQ24612082
Preexposure prophylaxis for HIV prevention: where have we been and where are we going?Q26825042
Antiretroviral prophylaxis for HIV prevention in heterosexual men and womenQ28270788
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trialQ28292876
Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San FranciscoQ28476730
No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxisQ28537713
Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San FranciscoQ28658226
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in BotswanaQ29620078
High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration projectQ30877918
Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detectionQ33185974
Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detectionQ33948938
Availability of HIV postexposure prophylaxis services in Los Angeles CountyQ34071050
HIV-1 drug resistance in the iPrEx preexposure prophylaxis trialQ34249966
Two years of Truvada for pre-exposure prophylaxis utilization in the US.Q34477239
Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trialQ35163040
Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or dual-agent preexposure prophylaxisQ35473551
Accuracy of Self-Report and Pill-Count Measures of Adherence in the FEM-PrEP Clinical Trial: Implications for Future HIV-Prevention TrialsQ35558205
Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled TrialQ36048957
Risk compensation: the Achilles' heel of innovations in HIV prevention?Q36417699
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trialQ36426896
No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice SettingQ36735089
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.Q37042094
Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health ServicesQ37296618
Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United StatesQ37524778
Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysisQ37577222
Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxisQ37665912
Evaluation of self-collected versus clinician-collected swabs for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae pharyngeal infection among men who have sex with men.Q37850060
High performance and acceptability of self-collected rectal swabs for diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in men who have sex with men and womenQ37854586
Adherence to antiretroviral medications for HIV pre-exposure prophylaxis: lessons learned from trials and treatment studiesQ38068661
P433issue2
P921main subjectlessons learnedQ1673259
P304page(s)116-124
P577publication date2016-02-22
P1433published inCurrent HIV/AIDS reportsQ26842190
P1476titleSuccessful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings
P478volume13

Reverse relations

cites work (P2860)
Q90292815A Cross-sectional Survey of Internal Medicine Resident Knowledge, Attitudes, Behaviors, and Experiences Regarding Pre-Exposure Prophylaxis for HIV Infection
Q63785465Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults' Perspectives
Q38850925Brief Report: Medication Sharing Is Rare Among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention
Q38657576Challenges in Translating PrEP Interest into Uptake in an Observational Study of Young Black MSM.
Q47568567Correlates of Linkage to HIV Pre-exposure Prophylaxis (PrEP) among HIV Testing Clients
Q92918284Global implementation of PrEP for HIV prevention: setting expectations for impact
Q47303141HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults
Q40049033HIV pre-exposure prophylaxis implementation at local health departments: a statewide assessment of activities and barriers
Q40446068Healthcare Access and PrEP Continuation in San Francisco and Miami After the US PrEP Demo Project
Q59358130Impact of Providing Preexposure Prophylaxis for Human Immunodeficiency Virus at Clinics for Sexually Transmitted Infections in Baltimore City: An Agent-based Model
Q40135129Interest in Long-Acting Injectable PrEP in a Cohort of Men Who have Sex with Men in China
Q58574198Location location location: an exploration of disparities in access to publicly listed pre-exposure prophylaxis clinics in the United States
Q89415225Modelling the Epidemiological Impact and Cost-Effectiveness of PrEP for HIV Transmission in MSM in China
Q64245540Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care
Q38985811Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care
Q33656112Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation
Q48567383Preexposure Prophylaxis of HIV Infection: the Role of Clinical Practices in Ending the HIV Epidemic
Q92343676Preferences for implementation of HIV pre-exposure prophylaxis (PrEP): Results from a survey of primary care providers
Q55420581Provider Adherence to Pre-exposure Prophylaxis Monitoring Guidelines in a Large Primary Care Network.
Q46771194Randomized Controlled Trial of Daily Text Messages To Support Adherence to PrEP In At-Risk for HIV Individuals: The TAPIR Study.
Q92158771Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP Care
Q64110144Scaling-up PrEP Delivery in Sub-Saharan Africa: What Can We Learn from the Scale-up of ART?
Q36286229Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi
Q38641903The Vaginal Microbiome and its Potential to Impact Efficacy of HIV Pre-exposure Prophylaxis for Women
Q42271267Top Questions in ID: Pre-exposure Prophylaxis for HIV.
Q38967290Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States.